Taiwan Firm AHEAD Medicine Disrupting Cell Analysis With AI to Help Accelerate Disease Diagnostics…
AHEAD Medicine, a UC Berkeley SkyDeck-backed company has launched a new AI-enabled cell immuno-profiling analysis platform. The platform unlocks the…